Concord Biotech Limited (BOM:543960)
India
· Delayed Price · Currency is INR 1,539.65
+6.00 (0.39%)
At close: May 9, 2025
Concord Biotech Revenue
Concord Biotech had revenue of 2.44B INR in the quarter ending December 31, 2024, with 1.42% growth. This brings the company's revenue in the last twelve months to 10.89B, up 12.22% year-over-year. In the fiscal year ending March 31, 2024, Concord Biotech had annual revenue of 10.17B with 19.20% growth.
Revenue (ttm)
10.89B
Revenue Growth
+12.22%
P/S Ratio
14.51
Revenue / Employee
7.91M
Employees
1,377
Market Cap
158.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 10.17B | 1.64B | 19.20% |
| Mar 31, 2023 | 8.53B | 1.40B | 19.67% |
| Mar 31, 2022 | 7.13B | 959.91M | 15.56% |
| Mar 31, 2021 | 6.17B | 1.05B | 20.42% |
| Mar 31, 2020 | 5.12B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |